-
EC eCQMs - Eligible Clinicians
-
Resolution: Answered
-
Moderate
-
None
-
None
-
-
CMS0347v7
CMS 347 - Statin Therapy for the Prevention and Treatment of CV Disease: The measure specification identifies Population 4 as 'Patients aged 40-75 years at the beginning of the measurement period with a 10-year ASCVD risk score >= 20 percent'.
In the following scenario, the patient had multiple ASCVD Risk scores calculated in the measurement period.
- Eligible visit on 1/4/2024 with ASCVD risk score of 19.3
- Eligible visit on 3/25/2024 with ASCVD risk score of 24.2
- Eligible visit on 6/21/2024 with ASCVD risk score of 19.5
Which ASCVD risk score should be utilized to determine inclusion in Population 4? Does an ASCVD risk score >= 20 at any time during the measurement period count or should we utilize the most recent ASCVD risk score which did not meet the >= 20 percent threshold?